资讯

Sarepta Therapeutics Announces Second Quarter 2025 Financial Results and Recent Corporate ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported ...

Sarepta rises on strong quarterly earnings and revenue

Shares of Sarepta Therapeutics (NASDAQ:SRPT) rose on Wednesday after the market as it reported second quarter revenue and ...
Investor's Business Daily on MSN47 分钟

Avidity Biosciences Rockets As Novartis Reportedly Mulls A Takeover Deal

Avidity Biosciences stock rocketed Wednesday on a report Novartis made an attempt to buy the rare disease-focused biotech ...